The epidemiology of hepatitis C virus in the fertile crescent: Systematic review and meta-analysis

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Chemaitelly, Hiam ^a   Chaabna, Karima ^a,b   Abu Raddad, Laith J ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CASE STUDY; CHILDHOOD CANCER; DISEASE TRANSMISSION; EFFECT SIZE; FOLLOW UP; GENOTYPE; HEALTH CARE FACILITY; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 2; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 4; HEPATITIS C VIRUS GENOTYPE 5; HEPATITIS C VIRUS GENOTYPE 6; HEPATITIS C VIRUS GENOTYPE 7; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION CONTROL; IRAQ; JORDAN; LEBANON; LOW RISK POPULATION; MASS SCREENING; MIGRATION; NONHUMAN; PALESTINE; PRACTICE GUIDELINE; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SEROCONVERSION; SYRIAN ARAB REPUBLIC; SYSTEMATIC REVIEW; THALASSEMIA; VIRUS STRAIN; HEPACIVIRUS; META ANALYSIS; MIDDLE EAST; PHYSIOLOGY; VIROLOGY;

HEPACIVIRUS; HEPATITIS C; HUMANS; INCIDENCE; MIDDLE EAST; PREVALENCE; RISK FACTORS;

EID: 84942871980     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135281     Document Type: Article

References (200)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCVseroprevalence. Hepatology. 2013;57(4):1333-42. doi: 10.1002/hep. 26141 PMID: 23172780.
2. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2011;17(2):107-15. doi: 10.1111/j.1469-0691.2010.03432.x PMID: 21091831.
3. World Health Organization. Hepatitis C: fact sheet Geneva, Switzerland [updated April 2014; cited 2015 02/02]. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/.
4. Centers for Disease Control and Prevention. Hepatitis C Atlanta, USA [updated August 1, 2013; cited 2015 02/02]. Available from: http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/hepatitis-c.
5. ∗ Once Daily Sofosbuvir/Ledipasvir Combination Elicits Rapid Decline in HCV RNA Gastroenterology & Hepatology. 2014;10(1 Suppl 1):1-19.
6. El-Zanaty F, Way A. Egypt Demographic and Health Survey 2008. Cairo: Egyptian Ministry of Health, National Population Council, El-Zanaty and Associates, and ORC Macro; 2009. 431 p.
7. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC infectious diseases. 2013;13:288. doi: 10.1186/1471-2334-13-288 PMID: 23799878; PubMed Central PMCID: PMC3702438.
8. Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HU. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sih-hiyah li-sharq al-mutawassit. 2010;16 Suppl: S15-23. PMID: 21495584.
9. Umar M, Bushra HT, Ahmad M, Data A, Ahmad M, Khurram M, et al. Hepatitis C in Pakistan: a review of available data. Hepatitis monthly. 2010;10(3):205-14. PMID: 22308140; PubMed Central PMCID: PMC3269085.
10. Chaabna K, Mohamoud YA, Chemaitelly H, Mumtaz GR, Abu-Raddad LJ. Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa. Systematic reviews. 2014;3:146. Epub 2014/12/18. doi: 10.1186/2046-4053-3-146 PMID: 25516265; PubMed Central PMCID: PMC4274704.
11. Mohamoud YA, Riome S, Abu-Raddad LJ. The epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analyses (under preparation). 2015.
12. Fadlalla FA, Mohamoud YA, Mumtaz GR, Abu-Raddad LJ. The epidemiology of hepatitis C virus in the maghreb region: systematic review and meta-analyses. PloSone. 2015;10(3):e0121873. doi: 10. 1371/journal.pone.0121873 PMID: 25803848; PubMed Central PMCID: PMC4372394.
13. Chaabna K., Kouyoumjian S., Abu-Raddad LJ. Hepatitis C virus prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa: Systematic review and meta-analysis (under preparation). 2015.
14. Chemaitelly H, Mahmud S, Abu-Raddad LJ. The epidemiology of hepatitis C in Afghanistan: Systematic review and meta-analyses (under preparation). 2015.
15. Mahmud S, Akbarzadeh V, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses (under preparation). 2015.
16. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097 PMID: 19621072; PubMed Central PMCID: PMC2707599.
17. Chaabna K, Mohamoud YA, Chemaitelly H, Mumtaz GR, Abu-Raddad LJ. Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in The Horn of Africa sub-region of the Middle East and North Africa. 2014. Available at: http://www.crd.york.ac.uk/NIHR PROSPERO/display-record.asp?ID=CRD42014010318#. VRpKHuEQuCd 2014.
18. Abu-Raddad L, Akala FA, Semini I, Riedner G, Wilson D, Tawil O. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: Time for strategic action. World Bank/UNAIDS/WHO Publication, editor. Washington DC: The World Bank Press; 2010.
19. Abu-Raddad LJ, Hilmi N, Mumtaz G, Benkirane M, Akala FA, Riedner G, et al. Epidemiology of HIV infection in the Middle East and North Africa. AIDS (London, England). 2010;24 Suppl 2:S5-23. doi: 10.1097/01.aids.0000386729.56683.33 PMID: 20610949.
20. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244(4902):359-62. PMID: 2523562.
21. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989;244(4902):362-4. PMID: 2496467.
22. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61 (1 Suppl):S45-57. doi: 10.1016/j.jhep. 2014. 07.027 PMID: 25086286.
23. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378(9791):571-83. doi: 10.1016/S0140-6736 (11) 61097-0 PMID: 21802134; PubMed Central PMCID: PMC3285467.
24. The Cochrane collaboration. Cochrane handbook for systematic reviews of interventions. Hoboken (New Jersey): Wiley-Blackweill; 2008.
25. Freeman MF, Tukey JW. Transformations Related to the Angular and the Square Root. Ann Math Statist. 1950;21(4):607-11.
26. Neyeloff JL, Fuchs SC, Moreira LB. Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC research notes. 2012;5:52. Epub 2012/01/24. doi: 10.1186/1756-0500-5-52 PMID: 22264277; PubMed Central PMCID: PMC3296675.
27. Borenstein M. Introduction to meta-analysis. Chichester, U. K.: John Wiley & Sons; 2009. xxviii, 421 p. p.
28. Higgins J, Thompson S, Deeks J, Altman D. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003;327:557-60.
29. Shannon CE. The mathematical theory of communication. 1963. MD computing: computers in medical practice. 1997;14(4):306-17. PMID: 9230594.
30. IBM Corporation. IBM SPSS Statistics for Windows, Version 22.0. Armonk, New York: IBM Corporation; 2013.
31. R Core Team. R 3.1.2: A language and environment for statistical computing. Vienna, Austria2014.
32. Additional country-level data provided through the MENA HIV/AIDS Epidemiology Synthesis Project database by the World Health Organization Regional Office for the Eastern Mediterranean. 2014.
33. Palestinian Health Information Center. Health Annual Report 2013. URL: http://www.moh.ps/?lang= 1&page=4&id= 939:2014.
34. Palestinian Health Information Center. Health Annual Report 2009. URL: http://www.moh.ps/?lang= 1&page=4&id=150:2010.
35. Palestinian Health Information Center. Health Annual Report 2007. URL: http://www.moh.ps/?lang= 1&page=4&id= 139:2008.
36. Palestinian Health Information Center. Health Annual Report 2006. URL: http://www.moh.ps/?lang= 1&page=4&id= 142:2007.
37. Palestinian Health Information Center. Health Annual Report 2005. URL: http://www.moh.ps/?lang= 1&page=4&id= 9:2006.
38. Palestinian Health Information Center. Health Annual Report 2003. URL: http://www.moh.ps/?lang= 1&page=4&id= 137:2004.
39. Batieha A, Abdallah S, Maghaireh M, Awad Z, Al-Akash N, Batieneh A, et al. Epidemiology and cost of haemodialysis in Jordan. Eastern Mediterranean Health Journal. 2007;13(3):654-63. PMID: 2007356348.
40. Al-Rubaie H. MH., Malik A. S. Seroconversion rate of hepatitis C virus infection among haemodialysis patients in Al-Kadhimiya Teaching Hospital (dialysis unit). Iraqi Journal of Medical Sciences. 2011;9(4):343-9.
41. Al-Ali N. AA., Al-Kayatt T. N. Seroprevalence of hepatitis B&Cin pediatric malignancies. Iraqi Postgraduate Medical Journal. 2014;13(2):262-7.
42. Al-Jadiry M. Viral hepatitis markers screen in children with acute lymphoblastic leukemia experience of Children Welfare Teaching Hospital. Journal of the Faculty of Medicine of Baghdad. 2008;50(2):223-30.
43. Al-Ani M. H., Rasul T. H. Hepatitis B and C viral infections in children with acute leukemia in Erbil city. Journal of the Arab Board of Health Specializations. 2011;12(1):21-9.
44. Al-Kubaisy W. A., Niazi A., Kubba K. Lackof mother-to-newborn transmission of hepatitis C virus in Iraqi women: a prospective study with hepatitis C virus RNA testing. Journal of the Arab Board of Health Specializations. 2000;2 (2).
45. Al-Kubaisy WA, Al-Naib KT, Habib M. Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia. Eastern Mediterranean health journal = La revue de sante de la Med-iterraneeorientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2006;12(1-2):204-10. Epub 2006/10/14. PMID: 17037239.
46. Abdul-Aziz M, Abdul-Karem K, Shamse-El-Den S, Al-Moula GA. Prevalence of hepatitis B & C among people attending Kirkuk Public Health Laboratory. Al-Taqani. 2001;23(3):6-15.
47. Abdullah B. A., Khaled M. D., Maarouf M. N. Detection of hepatitis C virus (HCV) by ELISA, RIBAand Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) technique among kidney dialysis patients in Nineveh governorate/Iraq. Science Journal of Thi-Qar 2012;3(2):55-67.
48. Abdullah AM, Hardan A, Latif II. Genotypingof hepatitis C virus isolates from Iraqi hemodialysis patients by reverse transcription-PCR and one step nested RT-PCR. Diyala Journal of Medicine. 2012;3(1):9-18.
49. Al-Dulaimi S. B. K., Al-Ubadi A. E., Al-Ubadi A. E., Al-Bayatti E. N., Al-Saday S. D. K. Toxoplasma gondii, HCV, and HBV seroprevalence in Haemodialysis patients with chronic renal failure in Al-Kindy Hospital Baghdad, Iraqi. Al-Mustansiriyah Journal of Science. 2012;23(5):33-8.
50. Al-Mashhadani JI. Hepatitis C virus infection among haemodialysis patients in Al-Anbargovernorate. Iraqi Journal of Community Medicine. 2007;20(1):20-3.
51. Khattab OS. Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2008;19(1):110-5. Epub 2007/12/19. PMID: 18087139.
52. Khattab O. S. How to decrease the prevalence of hepatitis C in Iraqi hemodialysis patients. The Iraqi Postgraduate Medical Journal. 2010;9(1):31-5.
53. Mnuti J. K., Al-Abbudi F. A. Hepatitis C virus infection assessment among chronic hemodialysis patients in Al-KadhmiyaTeaching Hospital. Iraqi Postgraduate Medical Journal. 2011;10(4):460-4.
54. Ramzi Z. S., Abdulla A. A., Al-Hadithi T., Al-Tawil N. Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in Sulaimani. Zanco Journal of Medical Sciences. 2010;14(1):44-50.
55. Shihab SS, Al-Hmudi HA, Al-Edani HS, Mahdi KH. Viral hepatitis infections in Basrah haemodialysis unit: serological diagnosis and viral loading. European Journal of Experimental Biology. 2014;4(2):106-12.
56. Al-Beldawi D. H. The risk factors of inhibitor development and hepatitis C virus among hemophilic patients in Children Welfare Teaching Hospital. Journal of the Faculty of Medicine of Baghdad. 2010;52(1):4-8.
57. Al-Thwani A. N., Al-Yassiri A. S. Using ELISA & ELFA for diagnosis of infection with hepatitis C, Band HIV viruses among Iraqi haemophilic patients. Iraqi Journal of Biotechnology. 2006;5(1):70-84.
58. Muhsin M. A., Abdul-Husin I. F. Seroprevalence of hepatitis B and C among thalassemic, haemophilic patients in Babylon Governorate-Iraq. Medical Journal of Babylon. 2013;10(2):445-54.
59. Tarky A. M., Akram W., Al-Naaimi A. S., Omer A. R. Epidemiology of viral heaptitis BandCin iraq: a national survey 2005-2006. Zanco Journal of Medical Sciences. 2013;17(1):370-80.
60. Al-Mashhadani J. I., Al-Hadithi T. S., Al-Diwan J. K., Omer A. R. Sociodemographiccharacteristics and riskfactors of hepatitis B and C among Iraqi health care workers. Journal of the Faculty of Medicine of Baghdad. 2009;51(3):308-11.
61. Al-Saad T, Al-Alousi BM, Khalaf NM, Abdul Razak W. Prevalence of hepatitis B and C viruses among medical staff in Ramadi General Hospital. Al-Anbar Medical Journal. 2009;7(1):68-75.
62. Hassan ZM, Wahsheh MA, Shishani KR, Pryor ER. Hepatitis needs assessment among Jordanian healthcare workers. International nursing review. 2008;55(2):142-7. Epub 2008/05/15. doi: 10.1111/j.1466-7657.2007.00583.x PMID: 18477097.
63. Noaman N. G. Prevalence of hepatitis C virus infection among blood donors and certain risky groups in Diyala Province. Diyala Journal of Medicine. 2012;2(1):46-52.
64. Saadoon A. A. Prevalence of viral hepatitis B and C among selected group in Thi-Qar. Thi-Qar Medical Journal. 2012;6(1):79-89.
65. Hussain AI, Anizy HH. Prevalence of viral hepatitis B and C among dentistry professionals in Anbar province. Journal of Al-Anbar University for Pure Science. 2008;2(2):18-24.
66. Al-Marzoqi A. H., Shemmran A. R., Al-Hindi Z., Al-Taee Z. M., Al-Nafee M. K. Bacterial and viral infections associated with thalassemia in Hillahcity. Journal of Al-Qadisiyah for Pure Science. 2009;14(3):1-15.
67. Albaitushi A., Tariq G., Mahmood M. Viral infections and diabetes mellitus. Journal of the Biotechnology Research Center. 2011;5(3):29-33.
68. Al-Sweedan SA, Jaradat S, Amer K, Hayajneh W, Haddad H. Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with beta-thalassemia major.[Turkish]. Multipl transfuzyon uygulanan beta-talasemi majorlu urdunlu hastalarda hepatit c virusunun seroprevalansi {dotless} ve genotiplemesi. Turkish Journal of Hematology. 2011;28(1):47-51. doi: http://dx.doi.org/10.5152/tjh.2011.05 PMID: 2011173285.
69. Quadan A. Prevalence of anti hepatitis C virus among the hospital populations in Jordan. The new microbiologica. 2002;25(3):269-73. Epub 2002/08/14. PMID: 12173766.
70. Al-Sheyyab M, Batieha A, El-Khateeb M. The prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers in multi-transfused patients. Journal of tropical pediatrics. 2001;47(4):239-42. Epub 2001/08/29. PMID: 11523766.
71. Mahfoud Z, Kassak K, Kreidieh K, Shamra S, Ramia S. Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon. Virology journal. 2010;7:96. Epub 2010/05/15. doi: 10.1186/1743-422x-7-96 PMID: 20465784; PubMed Central PMCID: PMC2885342.
72. Abdelnour GE, Matar GM, Sharara HM, Abdelnoor AM. Detection of anti-hepatitis C-virus antibodies and hepatitis C-virus RNAin Lebanese hemodialysis patients. European journal of epidemiology. 1997;13(8):863-7. Epub 1998/02/26. PMID: 9476813.
73. Naman RE, Mansour I, Klayme S, Khalil G. [Hepatitis C virus in hemodialysis patients and blood donors in Lebanon]. Le Journal medical libanaisThe Lebanese medical journal. 1996;44(1):4-9. Epub 1996/01/01. PMID: 8965318.
74. ∗ in the evaluation of cardiac Iron overload in patients with sickle cell disease. Haematologica. 2009;94:511-2. PMID: 70013481.
75. Ramia S, Koussa S, Taher A, Haraki S, Klayme S, Sarkis D, et al. Hepatitis-C-virus genotypes and hepatitis-G-virus infection in Lebanese thalassaemics. Annals of tropical medicine and parasitology. 2002;96(2):197-202. Epub 2002/06/26. doi: 10.1179/000349802125000439 PMID: 12080981.
76. Ramia S, Klayme S, Naman R. Infection with hepatitis B and C viruses and human retroviruses (HTLV-I and HIV) among high-risk Lebanese patients. Annals of tropical medicine and parasitology. 2003;97(2):187-92. Epub 2003/06/14. doi: 10.1179/000349803235001363 PMID: 12803874.
77. Araj GF, Kfoury-Baz EE, Barada KA, Nassif RE, Alami SY. Hepatitis C virus: prevalence in Lebanese blood donors and brief overview of the disease. Le Journal medical libanais The Lebanese medical journal. 1995;43(1):11-6. Epub 1995/01/01. PMID: 8676356.
78. Irani-Hakime N, Musharrafieh U, Samaha H, Almawi WY. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003. American journal of infection control. 2006;34(4):241-3. Epub 2006/05/09. doi: 10.1016/j.ajic.2005.06.009 PMID: 16679184.
79. Irani-Hakime N, Tamim H, Samaha H, Almawi WY. Prevalence of antibodies against hepatitis C virus among blood donors in Lebanon, 1997-2000. Clinical and laboratory haematology. 2001;23(5):317-23. Epub 2001/11/13. PMID: 11703415.
80. Nabulsi MM, Araj GF, Farah AE, Khalil AM. Hepatitis C virus antibodies in pregnant Lebanese women. Journal of obstetrics and gynaecology: the journal of the Institute of Obstetrics and Gynaecology. 1997;17(6):548. Epub 1997/01/01. doi: 10.1080/01443619768560 PMID: 15511954.
81. Ramia S, Ramlawi F, Kanaan M, Klayme S, Naman R. Frequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donors. Epidemiology and infection. 2005;133(4):695-9. Epub 2005/07/30. PMID: 16050516; PubMed Central PMCID: PMC2870298.
82. Salem Z, Nuwaiyri-Salti N, Ramlawi F, Ramia S. Hepatitis C virus infection in Lebanese patients with B-cell non-Hodgkin's lymphoma. European journal of epidemiology. 2003;18(3):251-3. Epub 2003/06/13. doi: 10.1023/a:1023380316098 PMID: 12800950.
83. Tamim H, Irani-Hakime N, Aoun JP, Khoury S, Samaha H, Almawi WY. Seroprevalence of hepatitis C virus (HCV) infection among blood donors: a hospital-based study. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis. 2001;24(1):29-35. Epub 2001/08/23. PMID: 11515608.
84. Baddoura R, Haddad C, Germanos M. Hepatitis B and C seroprevalence in the Lebanese population. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2002;8(1):150-6. Epub 2004/08/28. PMID: 15330570.
85. Yaghi C, Sharara AI, Rassam P, Moucari R, Honein K, Bou Jaoude J, et al. Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival. World Journal of Gastroenterology. 2006;12(22):3575-80. PMID: 2006318933.
86. Otrock ZK, Saab J, Aftimos G, Nasr F, Farhat FS, Khairallah S, et al. A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses. Pathology oncology research: POR. 2013;19(4):715-22. Epub 2013/05/09. doi: 10.1007/s12253-013-9634-0 PMID: 23653112.
87. Dumaidi K, Al-Jawabreh A. Prevalence of occult HBV among hemodialysis patients in two districts in the northern part of the West Bank, Palestine. Journal of medical virology. 2014;86(10):1694-9. doi: 10.1002/jmv. 24008 PMID: 24992542.
88. El-Kader YE-OA, Elmanama AA, Ayesh BM. Prevalence and risk factors of hepatitis Band C viruses among haemodialysis patients in Gaza strip, Palestine. Virology journal. 2010;7:210. Epub 2010/09/03. doi: 10.1186/1743-422x-7-210 PMID: 20809985; PubMed Central PMCID: PMC2942824.
89. Stulhofer A, Chetty A, Rabie RA, Jwehan I, Ramlawi A. The prevalence of HIV, HBV, HCV, and HIV-related risk-taking behaviors among Palestinian injecting drug users in the East Jerusalem Governor-ate. Journal of urban health: bulletin of the New York Academy of Medicine. 2012;89(4):671-6. Epub 2012/06/08. doi: 10.1007/s11524-012-9672-z PMID: 22674463; PubMed Central PMCID: PMC3535135.
90. Shemer-Avni Y, El Astal Z, Kemper O, El Najjar KJ, Yaari A, Hanuka N, et al. Hepatitis C virus infection and genotypes in Southern Israel and the Gaza Strip. Journal of medical virology. 1998;56(3):230-3. Epub 1998/10/23. PMID: 9783690.
91. Novack L, Shinar E, Safi J, Soliman H, Yaari A, Galai N, et al. Evaluation of pooled screening for anti-HCV in two blood services set-ups. Tropical medicine & international health: TM & IH. 2007;12(3):415-21. Epub 2007/02/23. doi: 10.1111/j.1365-3156.2006.01810.x PMID: 17313513.
92. Abdulkarim AS, Zein NN, Germer JJ, Kolbert CP, Kabbani L, Krajnik KL, et al. Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes. The American journal of tropical medicine and hygiene. 1998;59(4):571-6. Epub 1998/10/28. PMID: 9790432.
93. Moukeh G, Yacoub R, Fahdi F, Rastam S, Albitar S. Epidemiology of hemodialysis patients in Aleppo city. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2009;20(1):140-6. Epub 2008/12/30. PMID: 19112237.
94. Othman B, Monem F. Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus, Syria. Infection. 2001;29(5):262-5. Epub 2001/11/02. PMID: 11688903.
95. Syria Mental Health Directorate and National AIDS Programme (of Syrian Ministry of Health). Assessment of HIV risk and sero-prevalence among drug users in greater Damascus. Syrian Ministry of Health, United Nations Office on Drugs and Crime, and the Joint United Nations Programme on HIV/AIDS, 2008.
96. Ali T, Schved JF. Registry of hemophilia and other bleeding disorders in Syria. Haemophilia. 2012;18(6):851-4. Epub 2012/06/08. doi: 10.1111/j.1365-2516.2012.02862.x PMID: 22672010.
97. Othman BM, Monem FS. Prevalence of hepatitis C virus antibodies among intravenous drug abusers and prostitutes in Damascus, Syria. Saudi medical journal. 2002;23(4):393-5. Epub 2002/04/16. PMID: 11953762.
98. National AIDS Programme and Central Statistics Bureau (of Syrian Ministry of Health). Knowledge, attitude, and professional behavior of health care workers around certain blood-borne diseases including AIDS and hepatitis BandC. Syrian Ministry of Health, United Nations Development Programme, and the World Health Organization, date unknown.
99. Al-Azmeh J, Frosner G, Darwish Z, Bashour H, Monem F. Hepatitis E in Damascus, Syria. Infection. 1999;27(3):221-3. Epub 1999/06/23. PMID: 10378137.
100. Obied H. M., Alrodhan M. A., Mallah M. O. Molecular and immunological detection of hepatitis C virus infection among blood donors in Al-Muthanna province-Iraq. International Journal of Advanced Research. 2014;2(6):295-315.
101. Tawfeeq WF. Detection of hepatitis C virus infection and genotypes among seropositive blood donors by polymerase chain reaction in babylon Governorate, Iraq. Medical Journal of Babylon. 2013;10(1):25-37.
102. Al-Kubaisy WA, Niazi AD, Kubba K. History of miscarriage asa riskfactorforhepatitisC virus infection in pregnant Iraqi women. Eastern Mediterranean health journal = La revue de sante de la Mediterra-nee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2002;8(2-3):239-44. Epub 2004/09/02. PMID: 15339110.
103. Rashdan A, Hijjawi S, Jadallah K, Matalka I. Prevalence of hepatitis C virus antibodies among blood donors in Northern Jordan. Jordan Medical Journal. 2008;42(3):179-83. PMID: 2009005380.
104. Al-Kubaisy W. A., Obaid K. J., Noor N. M., Ibrahim N. S., Al-Azawi A. A. Hepatitis C virus prevalence and genotyping among hepatocellular carcinoma patients in Baghdad. Asian pacific Journal of Cancer Prevention. 2014;15(18):7725-30. PMID: 25292053
105. Chironna M, Germinario C, Lopalco PL, Carrozzini F, Barbuti S, Quarto M. Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey. Infection. 2003;31(2):70-4. Epub 2003/04/12. doi: 10.1007/s15010-002-3100-3 PMID: 12682810.
106. Al-Kubaisy WA, Al-Naib KT, Habib MA. Prevalence of HCV/HIV co-infection among haemophilia patients in Baghdad. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2006;12(3-4):264-9. Epub 2006/10/14. PMID: 17037693.
107. Othman AA, Eissa AA, Markous RD, Ahmed BD, Al-Allawi NA. Hepatitis C virus genotypes among multiply transfused hemoglobinopathy patients from Northern Iraq. Asian journal of transfusion science. 2014;8(1):32-4. Epub 2014/03/29. doi: 10.4103/0973-6247.126687 PMID: 24678171; PubMed Central PMCID: PMC3943142.
108. Abbas Y. A., Aubaid A. H., Hamad B. J. Determination of hepatitis C viral load and genotypes by Real-Time and RT-PCR at Thi-Qar province. Al-Qadisiah Medical Journal. 2013;9(15):250-64.
109. Al-hemiary R. M. The diagnostic value of hepatitis C genotyping by Real time-PCR in Iraqi patients. Iraq Journal of Market Research and Consumer Protection. 2012;4(2):159-67.
110. Khalid M. D., Abdullah B. A. Hepatitis C virus genotypes in Iraq. Iraqi Journal of Biotechnology. 2012;11(2):475-80.
111. Bdour S. Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping. Journal of medical microbiology. 2002;51(8):700-4. Epub 2002/08/13. PMID: 12171303.
112. Hamoudi W, Ali SA, Abdallat M, Estes CR, Razavi HA. HCV infection prevalence in a population recruited at health centers in Jordan. Journal of epidemiology and global health. 2013;3(2):67-71. Epub 2013/07/17. doi: 10.1016/j.jegh.2013.02.003 PMID: 23856567.
113. Mahfoud Z, Kassak K, Kreidieh K, Shamra S, Ramia S. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon. Journal of infection in developing countries. 2010;4(3):144-9. Epub 2010/03/31. PMID: 20351454.
114. Matar GM, Sharara HM, Abdelnour GE, Abdelnoor AM. Genotyping of hepatitis C virus isolates from Lebanese hemodialysis patients by reverse transcription-PCR and restriction fragment length polymorphism analysis of 5' noncoding region. Journal of clinical microbiology. 1996;34(10):2623-4. Epub 1996/10/01. PMID: 8880537; PubMed Central PMCID: PMC229338.
115. Irani-Hakime N, Samaha H, Almawi W, Nasr E, Mokhbat J, Abou Jaoude M, et al. Prevalence of hepatitis C virus isolate genotypes from chronically infected Lebanese patients: a hospital-based study. Le Journal medical libanaisThe Lebanese medical journal. 2003;51(3):121-6. Epub 2005/02/15. PMID: 15707071.
116. Sharara AI, Ramia S, Ramlawi F, Fares JE, Klayme S, Naman R. Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries. Epidemiology and infection. 2007;135(3):427-32. Epub 2006/07/20. doi: 10.1017/s0950268806006911 PMID: 16848924; PubMed Central PMCID: PMC2870582.
117. Inati A, Taher A, Ghorra S, Koussa S, Taha M, Aoun E, et al. Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection. British journal of haematology. 2005;130(4):644-6. Epub 2005/08/16. doi: 10.1111/j.1365-2141. 2005.05645.x PMID: 16098081.
118. Ayesh BM, Zourob SS, Abu-Jadallah SY, Shemer-Avni Y. Most common genotypes and risk factors for HCV in Gaza strip: a cross sectional study. Virology journal. 2009;6:105. Epub 2009/07/18. doi: 10.1186/1743-422x-6-105 PMID: 19607718; PubMed Central PMCID: PMC2716328.
119. Antaki N, Haddad M, Kebbewar K, Abdelwahab J, Hamed O, Aaraj R, et al. The unexpected discovery of a focus of hepatitis C virus genotype 5 in a Syrian province. Epidemiology and infection. 2009;137(1):79-84. Epub 2008/03/19. doi: 10.1017/s095026880800054x PMID: 18346288.
120. Karadat A. Hepatitis C genotypes in Syrian refugee patient in Turkey. Hepatology International. 2015;59 (1 SUPPL. 1):S276. http://dx.doi.org/10.1007/s12072-015-9609-1. PMID: 71806886.
121. Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61(1):77-87. doi: 10.1002/hep. 27259 PMID: 25069599; PubMed Central PMCID: PMC4303918.
122. Khaleel H. A., Turky A. M., Al-Naaimi A. S., Jalil R. W., Mekhlef O. A., Abdul Kareem S., et al. Prevalence of HBsAgandanti HCV Ab among patients with suspected acute viral hepatitis in Baghdad, Iraq in 2010. Epidemiology Reports. 2014;1 (1). doi: 10.7243/2054-9911-1-1
123. Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver international: official journal of the International Association forthe Study of the Liver. 2011;31 Suppl 2:30-60. Epub 2011/06/18. doi: 10. 1111/j.1478-3231.2011.02539.x PMID: 21651702.
124. Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion. 2010;50(7):1495-504. doi: 10.1111/j.1537-2995.2010.02622.x PMID: 20345570.
125. Denniston MM, Jiles RB, Drobeniuc J, Klevens RM, Ward JW, McQuillan GM, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Annals of internal medicine. 2014;160(5):293-300. doi: 10.7326/M13-1133 PMID: 24737271.
126. El-Ghitany EM, Abdel Wahab MM, Abd El-Wahab EW, Hassouna S, Farghaly AG. A comprehensive hepatitis C virus risk factors meta-analysis (1989-2013); Do they differ in Egypt? Liver international: official journal of the International Association for the Study of the Liver. 2015;35(2):489-501. doi: 10. 1111/liv. 12617 PMID: 24923487.
127. Mohamoud YA, Miller FD, Abu-Raddad LJ. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy bio-marker. World journal of gastroenterology: WJG. 2014;20(36):12734-52. doi: 10.3748/wjg.v20.i36. 12734 PMID: 25278675; PubMed Central PMCID: PMC4177460.
128. World Health Organization. WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings. 2015 WHO/HIS/SDS/2015.5.
129. WHO calls forworldwide use of "smart" syringes [Internet]. 2015; February 23. Available from: http://www.who.int/mediacentre/news/releases/2015/injection-safety/en
130. World Health Organization. Conflict and humanitarian crisis in Iraq Geneva, Switzerland: World Health Organization; 2014 [cited HQ/PEC/ERM/SCT/2014.4/PHRA 23/02/2015]. Available from: http://who.int/hac/crises/irq/iraq phra 24october2014.pdf.
131. World Health Organization. Annual report of the Regional Director2013: Emergency preparedness and response Switzerland, Geneva 2013 [23/02/2015]. Available from: http://www.emro.who.int/annual-report/2013/emergency-preparedness-and-response.html.
132. World Health Organization. Health emergency highlights. Emergency Risk Management and Humanitarian Response. 2014; (19:).
133. Alter MJ. Epidemiology of hepatitis C virus infection. World journal of gastroenterology: WJG. 2007;13(17):2436-41. PMID: 17552026; PubMed Central PMCID: PMC4146761.
134. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. The Lancet Infectious diseases. 2005;5(9):558-67. doi: 10.1016/S1473-3099 (05) 70216-4 PMID: 16122679.
135. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of internal medicine. 2006;144(10):705-14. PMID: 16702586.
136. Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, et al. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS medicine. 2014;11(6):e1001663. doi: 10.1371/journal.pmed.1001663 PMID: 24937136; PubMed Central PMCID: PMC4061009.
137. Hassan A. S. Prevalence of anti-hepatitis C virus antibodies among blood donors and risky groups in Diyala. Journal of the Faculty of Medicine of Baghdad. 2008;50(4):467-70.
138. Ramia S, Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2006;10(4):272-7. doi: 10.1016/j.ijid.2005.07.008 PMID: 16564719.
139. Taylor E. Egyptian Migration and Peasant Wives Middle East Research and Information Project 124. Washington: Middle East Research and Information Project
140. Feiler G. Migration and Recession-Arab Labor Mobility in the Middle-East, 1982-89. Popul Dev Rev. 1991;17(1):134-55. doi: 10.2307/1972356 PMID: WOS:A1991FP82100007.
141. Humphrey M. Migrants, workers and refugees: the political economy of population movements in the Middle East. Middle East report. 1993; (181:):2-7. PMID: 12179391.
142. International Organization for Migration. Migration and development in Egypt. 2010.
143. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. The Journal of infectious diseases. 1995;171(6):1607-10. PMID: 7769300.
144. Cuadros DF, Branscum AJ, Miller FD, Abu-Raddad LJ. Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications. Hepatology. 2014;60(4):1150-9. doi: 10.1002/hep. 27248 PMID: 24913187; PubMed Central PMCID: PMC4282472.
145. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(33):14757-62. doi: 10.1073/pnas.1008877107 PMID: 20696911; PubMed Central PMCID: PMC2930444.
146. Chemaitelly H, Abu-Raddad LJ, Miller FD. An apparent lack of epidemiologic association between hepatitis C virus knowledge and the prevalence of hepatitis C infection in a national survey in Egypt. PloSone. 2013;8(7):e69803. doi: 10.1371/journal.pone.0069803 PMID: 23922806; PubMed Central PMCID: PMC3726777.
147. Benova L, Awad SF, Miller FD, Abu-Raddad LJ. Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt. Hepatology. 2015;61(3):834-42. doi: 10.1002/hep. 27596 PMID: 25366418; PubMed Central PMCID: PMC4365684.
148. Guerra J, Garenne M, Mohamed MK, Fontanet A. HCV burden of infection in Egypt: results from a nationwide survey. Journal of viral hepatitis. 2012;19(8):560-7. doi: 10.1111/j.1365-2893.2011. 01576.x PMID: 22762140.
149. Abdul-Karim E. T. The prevalence of hepatitis in patients with congenital coagulation disorders. Journal of the Arab Board of Health Specializations. 2011;12(3):9-14.
150. Abed B. A. Prevalence of hepatitis C virus (HCV) among thalassemia patients in Ibn Al-Balady Hospital. Journal of Al-Nahrain University. 2010;13(1):121-6.
151. Albahadle AK. J., Abdul-Abass A., Ali A. H. Prevalence of hepatitis C infection among mutlitransfused thalassemia major patients in Ibn-AlBalady center for thalassemia. Al-Qadisiah Medical Journal. 2013;9(15):73-84.
152. Al-Barzinji RM. Patients with childhood leukemia are at high risk for transfusion-transmitted HBVand HCV infections. The Iraqi Postgraduate Medical Journal. 2006;5(4):442-6.
153. Al-Greti S. H. H. Prevalence of hepatitis C virus in beta-thalassemia major patients at Karbala gover-norate. Journal of Babylon University for Pure and Applied Sciences. 2013;21(8):2801-5.
154. Al-Juboori L. F. Hepatitis C virus in thalassemia patients in Tikrit. Medical Journal of Tikrit. 2012;1(181):95-100.
155. Al Wtaify AS, Hassan MK. Prevalence of hepatitis C virus infection among multitransfused thalasse-mic children in Basrah-Iraq. Qatar Medical Journal. 2000;9(2):58-61. PMID: 2001134222.
156. Al-Zamili A. H., Al-Shebani A. M., Mohsin R. K. Prevalence of hepatitis C viral infection among multi-transfused thalassemic patients. Al-Qadisiah Medical Journal. 2009;5(7):89-99.
157. Easa Z. O. Complications of high serum ferritin level after splenectomy in B thalassemic patients. Kufa Medical Journal. 2009;12(1):243-50.
158. Fadhil R. S., Al-Khalidi S. J., Hussien S. M., Hasoon H. A., Hussien R. A., Alwan L. H. Complications of HBV, HCV and HIV infections in patients with Coolyze Anemia in Baghdad. Iraqi Journal of Cancer and Medical Genetics. 2012;5(1):59-63.
159. Hashem N. A., Abdel-Rida Z. A., Taan G. M., Abdel-Hussein A. Spread of viral hepatitis among thalassemic patients in Maysan province. Al-Mustansiriyah Journal of Science. 2013;24(3):51-6.
160. Khaled M. D. Prevalence of hepatitis B, hepatitis C and human immunodeficiency virus infection among Thalassemia patients in Ninavha Governorate/Iraq. Journal of Biotechnology Research Center. 2014;8(2):11-3.
161. Khalid MD, Abdullah BA. Prevalence of anti-HCV antibodies among thalassemia patients in Mosul City, Iraq. Journal of Life Sciences. 2012;6(5):489-91.
162. Mustafa B. The prevalence of hepatitis-B and C serological markers among patients with thalassemia in Mosul. Iraqi Journal of Pharmacy. 2010;9 & 10(1):66-9.
163. Omer AR, Salih JI, Al-Nakshabandi AA. Frequency of blood-borne viral infections among leukemic patients in central Iraq. Saudi medical journal. 2011;32(1):55-61. Epub 2011/01/08. PMID: 21212918.
164. Omer W. A., Jamaleldin Z. A. Evaluation of some health and social parameters in Beta-thalassemia major patients in Ninawa governorate. Iraqi Medical Journal. 2011;57(2):106-10.
165. Raham TF, Abdul Wahed SS, Alhaddad H. N. Prevalence of hepatitis C among patients with Bthalas-semiain Diyala-IRAQ. Al-Taqani. 2011;24(4):113-20.
166. Al-Jamal M, Al-Qudah A, Al-Shishi KF, Al-Sarayreh A, Al-Quraan L. Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2009;20(3):488-92. Epub 2009/05/06. PMID: 19414962.
167. Batchoun RG, Al-Najdawi MA, Al-Taamary S. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2011;22(4):682-8. Epub 2011/07/12. PMID: 21743211.
168. Ghunaimat M., Al-Mrayat Z., Abbadi R., Akash N. Point prevalence of hepatitis C antibodies among hemodialysis patients at king Hussein Medical Center. Journal of the Royal Medical Services. 2007;14(2):63-7.
169. Said RA, Hamzeh YY, Mehyar NS, Rababah MS. Hepatitis C virus infection in hemodialysis patients in jordan. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 1995;6(2):140-3. Epub 1995/04/01. PMID: 18583853.
170. Othman BM, Monem FS. Prevalence of hepatitis C virus antibodies among health care workers in Damascus, Syria. Saudi medical journal. 2001;22(7):603-5. Epub 2001/08/02. PMID: 11479642.
171. Al-Azzawi M. K. K. Study of the spread of viral hepatitis pattern (C) among pregnant women in the city of Baquba. Journal of Diyala for Humanity Research 2006; (22:):106-12.
172. Al-Doori A. M. Prevalence of hepatitis B and hepatitis C among blood donors in Al-Anbar governorate. Journal of the Faculty of Medicine of Baghdad. 2006;48(2):149-51.
173. Al-Duliami A. A., Al-Kiali K. K., Hasan AR. Is there any relationship between hepatitis C virus infection and skin diseases? Diyala Journal of Medicine. 2012;3(1):51-6.
174. Al-Hamdani A. H., Al-Rawy S. K., Khamees H. A. Retrospective seroprevalence study of hepatitis B and C in Iraqi population at Baghdad: a hospital based study. Iraqi Journal of Community Medicine. 2012; (3:):186-90.
175. Ali MK. Prevalence of hepatitis B and hepatitis C among blood donors in Baghdad, August 2007-December 2008. Journal of the Faculty of Medicine of Baghdad University. 2009;51(4):419-22.
176. Al-Jebori A. S., Hassan A. S., Al-Duliami A. A. Seroprevalence of hepatitis Band hepatitis C virus infections in Diyala province during 2003-2008. Diyala Journal For Pure Science. 2010;6(1):292-302.
177. Aljooani O. AA., Al-Hayani N. N., Mohammed M. J. The infection with HBVand HCV and their relationship to ABO blood group among blood donors. Journal of the Faculty of Medicine of Baghdad. 2012;54(1):52-6.
178. Al-Juboury A. W. F., Salih H. A. L. M., Al-Assadi M. K., Ali A. M. Seroprevalence of Hepatitis B and C among blood donors in Babylon Governorate-Iraq. Medical Journal of Babylon. 2010;7 (1-2).
179. Al-Kamil E. A., Al-Yassin A. K. Transfusion transmitted diseases among blood donors of Basrah blood bank. Journal of the Arab Board of Health Specializations. 2011;12(1):35-40.
180. Amin RM. Prevalence of HBVand HCV in blood donors in Mosul city. Al-Taqani. 2012;25(2):70-7.
181. Ataallah TM, Hanan KA, Maysoun KS, Sadoon AA. Prevalence of hepatitis B and C among blood donors attending the National Blood Transfusion Center in Baghdad, Iraq from 2006-2009. Saudi medical journal. 2011;32(10):1046-50. Epub 2011/10/20. PMID: 22008925.
182. Chiad I. A., Al-Rubaii A., Al-Ani W., Al-Jaf A. A., Kadhem M. Sero-prevalence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among blood donors in the National Center of Blood Transfusion in Baghdad. Iraqi Journal of Community Medicine. 2009;22(4):215-7.
183. Fawzi N., Muhsin K. A. A. Screening for hepatitis B and hepatitis C viral infection among a sample of pregnant women in Al-Fallujah. Iraqi Medical Journal. 2011;57(2):119-25.
184. Hamim S. S. A survey study forthe prevalence of hepatitis A, B and C in Thi-Qar province for 2006-2010. Journal of College of Education for Pure Science. 2012;2(1):262-77.
185. Hamim S. S. Seroprevalence of hepatitis B and C among blood voluntaries in Iraq for 2008 and 2009. Journal of College of Education for Pure Science. 2012;2(2):125-4.
186. Hussain A. K., Mohammed S. H., Abd K. H. Screening of hepatitis Band C viral markers in Iraqi patients with proteinuria. Iraqi Postgraduate Medical Journal. 2008;7(4):362-8.
187. Hussein A. H. Seroprevalence of hepatitis B and C viruses among blood donors in Sulaimani Major Blood Bank for the years 2006 and 2007: a comparative study. Journal of Zankoy Sulaimani. 2010;13(1):15-20.
188. Hussain S. M., Hasan A. Does hepatitis C virus infection is a relevant factor for thyroid dysfunction. Diyala Journal for Pure Science. 2010;6(3):140-5.
189. Jassim A. N., Abdul-Hadi A. M., Al-Waysi S. A. Epidemiological study of viral hepatitis/Chibayish Marsh Reality in iraq. Journal of Baghdad for Science. 2011;8(1):23-8.
190. Naji MY, Abdulzahra AA, Hmood AR. Prevalence of viral hepatitis BandCin newly married persons. Kufa Journal for Nursing Sciences. 2013;3 (3).
191. Richter C, Ter Beest G, Gisolf EH, VANB P, Waegemaekers C, Swanink C, et al. Screening for chronic hepatitis BandCin migrants from Afghanistan, Iran, Iraq, the former Soviet Republics, and Vietnam in the Arnhem region, The Netherlands. Epidemiology and infection. 2014:1-7. Epub2014/01/09. doi: 10.1017/s0950268813003415 PMID: 24398373.
192. Saadoon I. H., Salih N. I., Saihood S. T. Hepatitis C virus infection and abortion among pregnant women in Mosul city. Medical Journal of Tikrit. 2008;1(141):161-4.
193. Salih N. I., Saadoon I. H. Seroprevalence of hepatitis C virus among risk groups in Mosul city. Tikrit Journal of Pharmaceutical Sciences. 2007;3(2):138-41.
194. Salman Y. G. Serological cross reaction among some causative agents of women abortions (Toxoplasma gondii & Cytomegalo virus & Rubella virus), with the incidence of hepatitis virus (B & C). Tikret Journal of Pharmaceutical Sciences. 2007;3(2):102-11.
195. Toffik K. A., Al-Diwan J. K., Al-Hadithi T. S., Al-Waiz M. M., Omer A. R. Prevalence of the serological markers of hepatitis B, C, and D among patients with sexually transmitted diseases (STDs) in Baghdad, Iraq. Journal of the Arab Board of Medical Specializations. 2006;8(1):105-9.
196. Al Abbadi B., Al Amr M., Abasi L, Saleem A., Abu Hazeem N., Marafi A. Seroprevalence of HBV, HCV, HIV and syphilis infections among blood donors at Blood Bank of King Hussein Medical Center: a 3 year study. Middle East Journal of Family Medicine 2014;12(6):10-3.
197. Al-Gani FA. Prevalence of HBV, HCV, and HIV-1, 2 infections among blood donors in Prince Rashed Ben Al-Hassan Hospital in North region of Jordan. International Journal of Biological & Medical Research. 2011;2(4):912-6.
198. Jbara I, Abu Alshiekh NK, Almomani AM, Khasawneh RH, Omari AK. Prevalence of hepatitis C virus antibodies among blood donors at Prince Hashem Hospital, Zarka-Jordan. Jordan Medical Journal. 2006;40(3):190-3. PMID: 2007107899.
199. Irani-Hakime N, Aoun J, Khoury S, Samaha HR, Tamim H, Almawi WY. Seroprevalence of hepatitis C infection among health care personnel in Beirut, Lebanon. American journal of infection control. 2001;29(1):20-3. Epub 2001/02/15. PMID: 11172314.
200. Ali T, Daher N. Prevalence des infections transmissibles par transfusion chez les donneurs de sang au centre de transfusion sanguine de l'universite de Damas et l'importance des mesures de la securite transfusionelle. Damscus University Journal of Health Sciences. 2010;26(1):107-23.